PI-LAB-2024-106

Orforglipron, Independent Lab Report

Orforglipron 36mg · Vector Peptide Supply

Verified

Independent testing verdict Pass

This product matched its label.

Identity confirmed and measured purity of 93.5% met the stated ≥95% claim. Content measured 100.8% of label.

Identity verified
Yes

Mass spectrometry confirmed the labelled compound

Measured purity
93.5%

Label claimed ≥95%

Content accuracy
100.8%

36.27mg measured against 36mg claimed

Test recency
Older result

Published 23 months ago

Specimen PI-LAB-2024-106 Tested by Vantage Analytical Labs 12 samples tested from this company Purity & Testing score 89/100

Full laboratory evidence Findings table, methodology, chain of custody and the original report

Findings

Metric Label claim Measured Assessment
Purity (HPLC) ≥ 95% 93.5% Within analytical tolerance
Identity (MS) Orforglipron Confirmed Matches label
Content 36 mg 36.27 mg Within 5% of label

Methodology & chain of custody

RP-HPLC purity with electrospray ionisation mass confirmation.

The sample was purchased anonymously through standard retail checkout and shipped to an unaffiliated address, then logged, photographed, and forwarded under chain-of-custody documentation to Vantage Analytical Labs. See our full testing methodology.

Lot / batch
A5463-24
Purchased
Analysed
Published
Laboratory
Vantage Analytical Labs
Test type
Purity & identity

Original laboratory report: PI-LAB-2024-106-report.pdf (document delivery arrives with the production storage backend)

More Tests, Vector Peptide Supply

Retatrutide
Purity 97.6% Verified
Vilon
Purity 93.1% Discrepancy
Tirzepatide
Purity 96.9% Verified

More Tests, Orforglipron

Orforglipron Cardinal Metabolic Clinic
Purity 98.6% Verified
Orforglipron Meridian Health Direct
Purity 98.1% Verified
Orforglipron Verity Research Chemicals
Purity 98.3% Verified